Stifel Nicolaus Has Lowered Expectations for American Well (NYSE:AMWL) Stock Price

American Well (NYSE:AMWL) had its price objective decreased by analysts at Stifel Nicolaus from $6.00 to $5.00 in a research report issued on Friday,Benzinga reports. The brokerage presently has a “hold” rating on the stock. Stifel Nicolaus’ target price indicates a potential downside of 6.98% from the stock’s current price.

AMWL has been the subject of a number of other reports. Wells Fargo & Company reduced their price target on shares of American Well from $12.00 to $9.00 and set an “overweight” rating for the company in a research report on Wednesday, November 5th. Weiss Ratings reiterated a “sell (e+)” rating on shares of American Well in a report on Wednesday, January 21st. Wall Street Zen cut American Well from a “hold” rating to a “sell” rating in a research report on Saturday, November 8th. Finally, Morgan Stanley dropped their target price on American Well from $10.50 to $6.00 and set an “equal weight” rating on the stock in a research report on Thursday, December 18th. One analyst has rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, American Well has an average rating of “Hold” and an average target price of $7.42.

American Well Trading Up 24.1%

Shares of AMWL stock opened at $5.38 on Friday. The stock has a market cap of $87.99 million, a P/E ratio of -0.90 and a beta of 1.36. American Well has a 1 year low of $3.71 and a 1 year high of $12.95. The stock has a 50 day simple moving average of $4.68 and a 200 day simple moving average of $5.45.

American Well (NYSE:AMWL) last posted its earnings results on Thursday, February 12th. The company reported ($1.52) EPS for the quarter, topping the consensus estimate of ($1.59) by $0.07. American Well had a negative net margin of 38.38% and a negative return on equity of 34.07%. The business had revenue of $55.31 million for the quarter, compared to the consensus estimate of $52.71 million. Analysts forecast that American Well will post -9.34 EPS for the current year.

Insider Activity

In other American Well news, insider Dmitry Zamansky sold 6,243 shares of the company’s stock in a transaction that occurred on Friday, January 2nd. The stock was sold at an average price of $4.85, for a total value of $30,278.55. Following the completion of the transaction, the insider owned 191,468 shares in the company, valued at $928,619.80. This represents a 3.16% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Over the last three months, insiders have sold 14,633 shares of company stock worth $67,972. 11.82% of the stock is owned by insiders.

Institutional Investors Weigh In On American Well

Hedge funds and other institutional investors have recently made changes to their positions in the company. Rock Point Advisors LLC boosted its holdings in shares of American Well by 49.3% in the third quarter. Rock Point Advisors LLC now owns 259,171 shares of the company’s stock valued at $1,594,000 after buying an additional 85,581 shares during the period. Monaco Asset Management SAM acquired a new stake in shares of American Well in the fourth quarter valued at approximately $338,000. Goldman Sachs Group Inc. grew its stake in American Well by 280.6% during the first quarter. Goldman Sachs Group Inc. now owns 64,760 shares of the company’s stock worth $510,000 after buying an additional 47,745 shares in the last quarter. Jane Street Group LLC boosted its position in shares of American Well by 232.9% during the 1st quarter. Jane Street Group LLC now owns 64,112 shares of the company’s stock worth $505,000 after acquiring an additional 44,852 shares in the last quarter. Finally, Marshall Wace LLP lifted its position in shares of American Well by 76.9% during the 4th quarter. Marshall Wace LLP now owns 87,447 shares of the company’s stock worth $429,000 after buying an additional 38,018 shares during the last quarter. 56.05% of the stock is owned by hedge funds and other institutional investors.

American Well News Summary

Here are the key news stories impacting American Well this week:

• Positive Sentiment: Q4 results beat consensus: AMWL reported ($1.52) EPS vs. consensus ($1.59) and revenue of $55.31M vs. $52.71M expected — a modest beat that suggests underlying demand. Read More.
• Neutral Sentiment: Earnings call and transcript available; analysts and media are parsing commentary for signs of margin improvement and CAC trends. Read More.
• Neutral Sentiment: Independent write-ups (Zacks, Benzinga) provide metric-by-metric comparisons to estimates and discuss where growth drivers and cost levers may lie. Read More.
• Negative Sentiment: Guidance materially below Street expectations: Q1 revenue guide of $48.0M–$53.0M vs. consensus ~$59.9M, and FY2026 revenue guide of $195M–$205M vs. consensus ~$243.5M — the guidance shortfall is the clearest near-term driver of downward pressure on the stock. Read More.
• Negative Sentiment: Analyst action: Stifel cut its price target to $5.00 and moved to a “hold” — about a 7% downside from the current ~$5.38 level — reinforcing cautious sentiment after the outlook miss. Read More.

About American Well

American Well, operating under the trade name Amwell, is a Boston-based digital health company that develops and delivers telehealth solutions to healthcare providers, payers, employers and patients. Through its cloud-based platform, the company enables secure virtual visits, remote patient monitoring and integrated care coordination across a range of medical disciplines, including primary care, behavioral health, chronic disease management and urgent care.

The company’s core offering, the Amwell Telehealth Platform, facilitates live video consultations, asynchronous messaging, e-prescribing and electronic health record integration.